- Home
- WTTR vs ARDX Comparison
WTTR vs ARDX Comparison
Compare WTTR & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTTR
- ARDX
- Stock Information
- Founded
- WTTR 2016
- ARDX 2007
- Country
- WTTR United States
- ARDX United States
- Employees
- WTTR N/A
- ARDX N/A
- Industry
- WTTR Oilfield Services/Equipment
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- WTTR Energy
- ARDX Health Care
- Exchange
- WTTR Nasdaq
- ARDX Nasdaq
- Market Cap
- WTTR 1.3B
- ARDX 1.4B
- IPO Year
- WTTR 2017
- ARDX 2014
- Fundamental
- Price
- WTTR $12.35
- ARDX $5.06
- Analyst Decision
- WTTR Strong Buy
- ARDX Buy
- Analyst Count
- WTTR 2
- ARDX 8
- Target Price
- WTTR $16.25
- ARDX $9.93
- AVG Volume (30 Days)
- WTTR 1.0M
- ARDX 3.6M
- Earning Date
- WTTR 02-18-2025
- ARDX 02-20-2025
- Dividend Yield
- WTTR 2.27%
- ARDX N/A
- EPS Growth
- WTTR N/A
- ARDX N/A
- EPS
- WTTR 0.30
- ARDX N/A
- Revenue
- WTTR $1,452,075,000.00
- ARDX $333,615,000.00
- Revenue This Year
- WTTR $6.26
- ARDX $169.30
- Revenue Next Year
- WTTR $6.87
- ARDX $14.87
- P/E Ratio
- WTTR $41.04
- ARDX N/A
- Revenue Growth
- WTTR N/A
- ARDX 168.06
- 52 Week Low
- WTTR $8.12
- ARDX $4.32
- 52 Week High
- WTTR $15.14
- ARDX $9.83
- Technical
- Relative Strength Index (RSI)
- WTTR 40.99
- ARDX 41.70
- Support Level
- WTTR $12.24
- ARDX $5.37
- Resistance Level
- WTTR $13.50
- ARDX $6.55
- Average True Range (ATR)
- WTTR 0.54
- ARDX 0.31
- MACD
- WTTR -0.04
- ARDX -0.02
- Stochastic Oscillator
- WTTR 13.49
- ARDX 0.67
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates the majority of its revenue from Water Services.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.